December 2020

Column

Editor's Page

Advancing Technologies for Clinician Decision Support

12/16/2020

Winston Wong, PharmD

The volume of clinical information that physicians need to retain in order to help determine the best treatment options for their patients is growing to an untenable level. While the amount of data and research is...

The...

12/16/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Digital Health Placement in Clinical Pathways

12/16/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Brian C Abraham, MPA

Martin Culjat, PhD

The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...

The...

12/16/2020

Journal of Clinical Pathways

COA Viewpoint

Preliminary Comment Letter on Most Favored Nation Experiment and Impact on Older Adults With Cancer

12/16/2020

Nicolas Ferreyros, Managing Director, Community Oncology Alliance

Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...

...

12/16/2020

Journal of Clinical Pathways

Trending From ACCC

Concerns About the Real-World Impact of CMS’ Radiation Oncology Model

12/16/2020

Association of Community Cancer Centers

While the Association of Community Cancer Centers (ACCC) supports the Center for Medicare and Medicaid Innovation (CMMI) Radiation Oncology (RO) Model’s concept and the transition to value-based care, ACCC has...

While...

12/16/2020

Journal of Clinical Pathways

Pathways Survey

The State of Clinical Pathways: Results From the Journal of Clinical Pathways Benchmarking Survey

12/16/2020

Winston Wong, PharmD

The Journal of Clinical Pathways (JCP) conducted its third annual survey to better understand pathway use in US oncology practices and cancer centers. Each year this data continues to provide a wealth of information...

The...

12/16/2020

Journal of Clinical Pathways

Pharma Insights

Does COVID-19 Threaten the Progress Pharmaceuticals Have Made in Reducing Cancer Mortality Over the Last 20 Years?

12/16/2020

Joanna P MacEwan, PhD

Jason Shafrin, PhD

Farzad Ali, BPharm, MS

The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...

The...

12/16/2020

Journal of Clinical Pathways

Department

Research in Review

12/16/2020

JCP Editors

Reviewing the latest research on value-based care, clinical pathways, and precision medicine Cancer Care Pathways in Secondary/Tertiary Care Associated With Shorter LOS Cancer care pathways in secondary/tertiary...

...

12/16/2020

Journal of Clinical Pathways

News

Conference Coverage

The 2020 American Society of Hematology Annual Meeting & Exposition

12/16/2020

JCP Editors

The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100 countries. The ASH...

The...

12/16/2020

Journal of Clinical Pathways

Insights

Interview

Building Clinical Pathways With an Emphasis on Specific Community Needs

12/16/2020

Carla Baker, RN, discusses the Memphis Breast Cancer Consortium, including the organization's mission, structure, and approach to pathways design.

Carla Baker, RN, discusses the...

12/16/2020

Journal of Clinical Pathways

Feature

Research Reports

The Impact of a Clinical Decision Support System for Advanced Gastric or Gastroesophageal Junction Cancer

12/16/2020

Scott Paulson, MD

Lisa M Hess, PhD

Anindya Chatterjee, PhD

Marley Boyd, MS

Kathleen M Aguilar, MPH

Astra M Liepa, PharmD

Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult patients...

...

12/16/2020

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

December 2020

Column

Department

News

Insights

Feature

Current Issue

Special Reports

Subscribe

December 2020 Volume 6

Specialties

Events

Year Round Education

HMP Global Products